[go: up one dir, main page]

WO2008146835A1 - Composition for promoting equol production in the blood of subject unable to produce equol - Google Patents

Composition for promoting equol production in the blood of subject unable to produce equol Download PDF

Info

Publication number
WO2008146835A1
WO2008146835A1 PCT/JP2008/059789 JP2008059789W WO2008146835A1 WO 2008146835 A1 WO2008146835 A1 WO 2008146835A1 JP 2008059789 W JP2008059789 W JP 2008059789W WO 2008146835 A1 WO2008146835 A1 WO 2008146835A1
Authority
WO
WIPO (PCT)
Prior art keywords
equol
blood
composition
production
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/059789
Other languages
French (fr)
Japanese (ja)
Inventor
Hideo Araki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Metropolitan Foundation for Res on Aging and Promotion of Welfare
Fuji Oil Co Ltd (fka Fuji Oil Holdings Inc)
Original Assignee
Fuji Oil Co Ltd
Tokyo Metropolitan Foundation for Res on Aging and Promotion of Welfare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Oil Co Ltd, Tokyo Metropolitan Foundation for Res on Aging and Promotion of Welfare filed Critical Fuji Oil Co Ltd
Priority to JP2009516332A priority Critical patent/JP5517613B2/en
Publication of WO2008146835A1 publication Critical patent/WO2008146835A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

It is intended to provide a composition effective for the production of equol in the blood which is to be used for a subject being unable to produce equol by metabolizing daidzein in vivo. Namely, a composition or the like for promoting equol production in the blood of a subject being unable to produce equol, which is characterized by comprising a daidzein type isoflavone and non-fat solid milk components, is provided.
PCT/JP2008/059789 2007-05-28 2008-05-28 Composition for promoting equol production in the blood of subject unable to produce equol Ceased WO2008146835A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009516332A JP5517613B2 (en) 2007-05-28 2008-05-28 Composition for promoting blood equol production for non-equol producers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007140538 2007-05-28
JP2007-140538 2007-05-28

Publications (1)

Publication Number Publication Date
WO2008146835A1 true WO2008146835A1 (en) 2008-12-04

Family

ID=40075072

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/059789 Ceased WO2008146835A1 (en) 2007-05-28 2008-05-28 Composition for promoting equol production in the blood of subject unable to produce equol

Country Status (2)

Country Link
JP (1) JP5517613B2 (en)
WO (1) WO2008146835A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020004568A1 (en) 2018-06-28 2020-01-02 アサヒグループホールディングス株式会社 Equol production promotor and food or beverage composition comprising same for promotion of equol production

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007392A1 (en) * 1997-08-08 1999-02-18 Otsuka Pharmaceutical Co., Ltd. Isoflavone-containing compositions
WO2000064438A1 (en) * 1999-04-28 2000-11-02 Novogen Research Pty Ltd Cardiovascular and bone treatment using isoflavones
JP2004222670A (en) * 2003-01-27 2004-08-12 Katori Kaitaku Nogyo Kyodo Kumiai Milk-soy milk mixed liquid fermented yogurt and method for producing milk-soy milk mixed liquid fermented yogurt
WO2005000042A1 (en) * 2003-06-30 2005-01-06 Otsuka Pharmaceutical Co., Ltd. Composition containing lactic acid bacterium producing equol
JP2005058088A (en) * 2003-08-12 2005-03-10 Sanei Beans:Kk Method for producing milk-containing tofu and tofu
WO2005092121A2 (en) * 2004-03-19 2005-10-06 Nestec S.A. Delivery of functional ingredients

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007392A1 (en) * 1997-08-08 1999-02-18 Otsuka Pharmaceutical Co., Ltd. Isoflavone-containing compositions
WO2000064438A1 (en) * 1999-04-28 2000-11-02 Novogen Research Pty Ltd Cardiovascular and bone treatment using isoflavones
JP2004222670A (en) * 2003-01-27 2004-08-12 Katori Kaitaku Nogyo Kyodo Kumiai Milk-soy milk mixed liquid fermented yogurt and method for producing milk-soy milk mixed liquid fermented yogurt
WO2005000042A1 (en) * 2003-06-30 2005-01-06 Otsuka Pharmaceutical Co., Ltd. Composition containing lactic acid bacterium producing equol
JP2005058088A (en) * 2003-08-12 2005-03-10 Sanei Beans:Kk Method for producing milk-containing tofu and tofu
WO2005092121A2 (en) * 2004-03-19 2005-10-06 Nestec S.A. Delivery of functional ingredients

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020004568A1 (en) 2018-06-28 2020-01-02 アサヒグループホールディングス株式会社 Equol production promotor and food or beverage composition comprising same for promotion of equol production

Also Published As

Publication number Publication date
JP5517613B2 (en) 2014-06-11
JPWO2008146835A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
LTPA2018510I1 (en) Derivatives of dioxa-bicyclo [3.2.1] octane-2,3,4-triol
EP2190307A4 (en) Preparation method of vegetable extract ferment solution and vegetable extract ferment solution prepared by the same
WO2008023266A3 (en) Kiwi extract
IL194865A0 (en) Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
WO2008130989A3 (en) Prosthetic implants
ZA200908722B (en) Freeze-dried,aerated dairy or diary-substitute compositions and methods of making thereof
SG10201704771TA (en) Fermented whey preparation and method for producing the same
PL381032A1 (en) Machine used to produce drinks on the basis of milk
LT2679676T (en) Methods and organisms for the growth-coupled production of 1,4-butanediol
PL2438178T3 (en) Microorganisms for the production of 1,4-butanediol and related methods
IL216609A0 (en) Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
WO2010112494A3 (en) Mixed drink
WO2008020765A3 (en) Imaging medium comprising lactate and hyperpolarised 13c-pyruvate
BRPI0714474A2 (en) "FOOD ADDITIVE, FIBER FORGED FOOD, METHOD FOR FORTIFYING FIBER FOOD AND FIBER FORTICATED DRINK"
BRPI1015441A2 (en) "composition comprising caffeoyloxycemic acids, protocatechuic acid hydroxytyrosol, hydroxybenzoic acid and derivatives thereof, and method of preparation"
WO2008058233A3 (en) In vivo bioreactors and methods of making and using same
WO2008128766A3 (en) Beverage composition
WO2008155998A1 (en) Antianxiety/antidepressant agent
PL1856988T3 (en) Flavonoid sugar addition products, method for manufacture and use thereof
BRPI0919352A2 (en) Enzyme preparation for bonded and shaped foods, and method for producing bonded and shaped foods.
LT1928255T (en) Method for the production of milk products, products thereby obtained, and use thereof
EP2036916A4 (en) Composition for promoting the production of equol
WO2008146835A1 (en) Composition for promoting equol production in the blood of subject unable to produce equol
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
WO2009053742A3 (en) Salts of nefopam and their use in therapy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08764805

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009516332

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08764805

Country of ref document: EP

Kind code of ref document: A1